Breeze Meds vs Novi: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Novi beats Breeze Meds overall, scoring 7.8/10 vs 7.3/10. Novi is more affordable at $133/mo vs $199/mo. Choose Breeze Meds for users who want to order compounded glp-1s month-by-month wit. Choose Novi for cash-pay patients who want compounded semaglutide or tirzepa.
A side-by-side look at Breeze Meds and Novi to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
Breeze Meds
#33 of 53Compounded GLP-1 provider focused on fast shipping and a no-fuss enrollment process.
Visit Breeze MedsNovi
#12 of 53Telehealth platform for compounded semaglutide and tirzepatide with month-to-month billing, six named clinicians on staff, and a 3-minute pre-approval quiz. Novi emphasizes 'all-in transparent' pricing, medication, supplies, unlimited clinician check-ins, dose adjustments, and weight-loss coaching are bundled with no add-on fees. Standard pricing is $174/mo semaglutide and $283/mo tirzepatide; promotional pricing on the offer landing drops to $99-$133/mo semaglutide and $149-$166/mo tirzepatide with $200 off advertised.
Visit Novi| Feature | Breeze Meds | Novi |
|---|---|---|
| Our Score | 7.3/10 | 7.8/10 |
| Starting Price | $199/mo | $133/mo |
| Medication Type | Compounded | Compounded |
| Insurance Accepted | No | No |
| Best For | Users who want to order compounded GLP-1s month-by-month with no subscription commitment | Cash-pay patients who want compounded semaglutide or tirzepatide on a no-commitment plan with named clinicians, unlimited check-ins, and aggressive promotional pricing as low as $99-$133/mo on the introductory offer |
| Watch out for | Independent reviews are very limited and the company structure is unclear, so legitimacy is hard to verify. Ask for pharmacy details first; the no-subscription model at least keeps a first order low-commitment. | Compounded-only, no FDA-approved Wegovy, Zepbound, Ozempic, or Mounjaro through the platform; no Foundayo or oral GLP-1 formats |
| Ranking | #33 | #12 |
| Get started | Visit Breeze Meds | Visit Novi |
Pros & Cons Compared
Breeze Meds
Pros
- +No subscription required, order on demand without recurring billing commitments
- +Three formulation options: injectable semaglutide, oral semaglutide tablet, and oral tirzepatide tablet
- +FSA/HSA eligible for those with health savings accounts
- +Discreet packaging on all shipments
Cons
- −Independent reviews are very limited and the company structure is unclear, so legitimacy is hard to verify. Ask for pharmacy details first; the no-subscription model at least keeps a first order low-commitment.
- −Oral options at $299-399/mo cost significantly more than injectable alternatives. The $199 injectable semaglutide is the value pick unless tablets are a must.
- −Not available in all 50 states; availability depends on provider licensure, so check your state early in the online visit.
Novi
Pros
- +Six disclosed clinicians on staff, Daniel Funsch MD, Michael Wasef MD, Takashi Nakamura MD plus three nurse practitioners (Hastings NP, Clements NP, Vergara DNP), more named providers than most compounded-only platforms publish
- +Month-to-month billing with no minimum commitment, cancel before any renewal date with no early-termination penalty
- +Aggressive promotional pricing on the offer landing, $99-$133/mo compounded semaglutide and $149-$166/mo compounded tirzepatide with a $200 OFF intro discount
- +Unlimited clinician check-ins, dose adjustments, and weight-loss coaching included at no additional cost
- +Free 2-day shipping; same active ingredients as Wegovy/Ozempic and Mounjaro/Zepbound (semaglutide and tirzepatide respectively)
- +100,000+ patients claimed and editorial coverage in Bloomberg, Forbes, and WebMD provide third-party signal
Cons
- −Compounded-only, no FDA-approved Wegovy, Zepbound, Ozempic, or Mounjaro through the platform; no Foundayo or oral GLP-1 formats
- −Founding year, headquarters city, and corporate ownership are not publicly disclosed
- −Promotional $99-$133 pricing applies to the introductory offer landing only, standard rate after any qualifying intro period is $174-$283/mo (verify the renewal rate before enrolling)
- −Once medication is dispensed/shipped, prescriptions cannot be returned or refunded, typical for compounded telehealth but worth understanding
- −Lab requirements before prescribing are not disclosed on public pages, unclear whether baseline bloodwork is required
- −Multiple landing pages (offer-v4, offer-v6-low) show different headline prices, which can create pricing confusion before checkout
Our Verdict
Novi edges out Breeze Meds with a score of 7.8/10 vs 7.3/10. If budget is your priority, Novi starts at $133/mo compared to Breeze Meds's $199/mo. Choose Breeze Meds if you want: users who want to order compounded glp-1s month-by-month with no subscription commitment. Choose Novi if you want: cash-pay patients who want compounded semaglutide or tirzepatide on a no-commitment plan with named clinicians, unlimited check-ins, and aggressive promotional pricing as low as $99-$133/mo on the introductory offer.
Still undecided? Editor's Featured Pick
TrimRx
$149/mo · 7.8/10 · Compounded
If neither Breeze Meds nor Novi feels like the right fit, our featured pick across all 53 GLP-1 telehealth providers is TrimRx. It is not the highest-scored provider in our full rankings. We feature it for its low-friction value: a flat $149/mo that stays the same at every dose.
Read Full Reviews
Related comparisons
Other matchups readers comparing Breeze Meds or Novi tend to look at next.
- Breeze Meds vs MyStart Health$299/mo
- Breeze Meds vs Direct Meds GLP-1$297/mo
- Breeze Meds vs Maximus$150/mo
- Novi vs DudeMeds$149/mo
- Novi vs Tonik Wellness$149/mo
- Novi vs MyStart Health$299/mo
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.